Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, October 9, 2025

Funding secured by Irish university spin-out to develop breakthrough stroke rehab technology

 No research presented so impossible to tell if this is working at all. No articles for 'cueStim-Stroke' in Google Scholar.
And your competent? doctor has generated protocols on this years ago, right? 
OH NO, YOU HAVE AN INCOMPETENT? DOCTOR! RUN AWAY!

Google does give us this: but no proof. 

cueStim-Stroke is a new bilateral sensory electrical stimulation device for post-stroke gait rehabilitation, developed by Fortis Medical Devices, a University of Galway spin-out. This wearable device aims to help stroke survivors improve their gait by providing rhythmic electrical cues to both sides of the body, promoting neuroplasticity and improving functional walking. The technology leverages a patented stimulator platform, similar to Fortis's Parkinson's disease treatment, to address gait impairments and enhance quality of life

Funding secured by Irish university spin-out to develop breakthrough stroke rehab technology

A consortium led by University of Galway spin-out Fortis Medical Devices has received the grant from the Irish Government to accelerate the development of their innovative device which will benefit post-stroke patients.

The cueStim-Stroke is a new wearable device designed for patients affected by post-stroke gait irregularities, which the consortium describes as a “major unmet clinical need”.

Nearly 20 million stroke patients worldwide are affected by long-term gait impairments.

“Stroke-related treatment and care costs are projected to reach €86 billion a year in the EU by 2040, underscoring the urgent need for transformative technologies,” a University of Galway spokesperson explained.

“This is a fantastic achievement for Fortis Medical and a great example of a successful University of Galway research-led spinout from the University ecosystem that will deliver disruptive ground-breaking technology for post-stroke gait rehabilitation, which will make a major impact for patients,” Professor Lokesh Joshi, the University of Galway’s Vice-President of Research and Innovation, said.

Spiddal-based Fortis Medical Devices is a client company of Údarás na Gaeltachta, along with RCSI University of Medicine and Health Sciences, and Smart Electronics, Shannon.

Their €2.1m grant was awarded through the Department of Enterprise, Trade and Employment’s Disruptive Technologies Innovation Fund (DTIF).

The consortium will also create a connected health ecosystem to support home-based rehabilitation, “providing clinicians with real-time data on gait performance, patient progress, and adherence, enabling continuous improvement in patient outcomes through data-driven insights”, they confirmed this week.

“Our mission is to significantly improve the quality of life for stroke survivors,” Thomas Gutierrez, Chief Executive of Fortis Medical Devices, said.

“With this DTIF award, we can accelerate the development of cueStim-Stroke to bring real-world solutions to patients and clinicians.”

Tomás Ó Síocháin, Chief Executive, Údarás na Gaeltachta, said they are “extremely proud” of Fortis Medical Devices’s achievement.

“This is an excellent example of the innovation and entrepreneurship taking place in the Gaeltacht,” he added.

“This DTIF grant demonstrates the potential of Gaeltacht companies to develop groundbreaking technologies with global impact, while creating employment and economic growth in our communities."

No comments:

Post a Comment